Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
47,044,110
-
Share change
-
-677,578
-
Total reported value
-
$8,388,424,595
-
Put/Call ratio
-
488%
-
Price per share
-
$178.30
-
Number of holders
-
200
-
Value change
-
-$134,114,517
-
Number of buys
-
87
-
Number of sells
-
105
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2023
As of 30 Jun 2023,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,044,110 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, HHLR ADVISORS, LTD., PRIMECAP MANAGEMENT CO/CA/, BAILLIE GIFFORD & CO, Temasek Holdings (Private) Ltd, FMR LLC, Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, and Capital International, Inc./CA/.
This page lists
200
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.